Continuous direct compression can provide a simplified alternative pathway for selected spray-dried dispersion formulations ...

As 3D printers become more accessible and easier to use, researchers are finding new ways to incorporate this technology into their work. 1 3D bioprinters utilizing natural, synthetic, and hybrid ...

McKesson plans to absorb Precision Medicine Group into Oncology & Multispecialty, adding CRO, lab, biomarker, market access, and commercialization capabilities to its existing healthcare services ...

FDA priority review of Jemperli for biomarker-defined rectal cancer signals capacity, supply chain, and global filing shifts ...

Content on PharmTech.com this week showed that while AI is being utilized in drug discovery, manufacturing execution still lags behind. However, manufacturers are rethinking where and how they build ...

FDA imposed a clinical hold on RGX-121 after spine MRI surveillance detected asymptomatic spinal nodules/cystic masses in five participants dosed intracisternally or intraventricularly 3–6 years prior ...

Schmitt and Schniepp stress that merely citing a standard (e.g., "we followed GAMP") doesn't guarantee compliance. According ...

On August 19,2026, the FDA accepted Teva Pharmaceuticals' New Drug Application (NDA) for ecopipam, an investigational ...

Chris Williams serves as executive director, Analytical Development ILM at Alcami, bringing more than a decade of experience ...

Annex 1 is driving investments in HVAC, water/clean utilities, environmental monitoring, barrier technologies, and facility remediation, with true maturity defined by QRM altering capital ...

Economic asymmetry after cartridge introduction drives a design philosophy centered on minimizing false acceptances and protecting API, with >99.5% first-pass yield as the principal success criterion.

Accelerated approval relies on cornstarch-reduction as a surrogate endpoint, with crossover follow-up planned at 96 and 144 ...